Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet

Biosci Rep. 2012 Oct;32(5):479-90. doi: 10.1042/BSR20120036.

Abstract

The propensity of LDLs (low-density lipoproteins) for aggregation and/or oxidation has been linked to their sphingolipid content, specifically the levels of SM (sphingomyelin) and ceramide. To investigate this association in vivo, ldlr (LDL receptor)-null mice (ldlr-/-) were fed on a modified (atherogenic) diet containing saturated fats and cholesterol. The diet led to significantly elevated SM content in all serum lipoproteins. In contrast, ceramide increased only in the LDL particles. MS-based analyses of the lipid acyl chain composition revealed a marked elevation in C16:0 fatty acid in SM and ceramide, consistent with the prevalence of palmitic acid in the modified diet. The diet also led to increased activity of the S-SMase [secretory SMase (sphingomyelinase)], a protein that is generated by ASMase (acid SMase) and acts on serum LDL. An increased macrophage secretion seemed to be responsible for the elevated S-SMase activity. ASMase-deficient mice (asm-/-/ldlr-/-) lacked S-SMase activity and were protected from diet-induced elevation in LDL ceramide. LDL from asm-/-/ldlr-/- mice fed on the modified diet were less aggregated and oxidized than LDL from asm+/+/ldlr-/- mice. When tested in vitro, the propensity for aggregation was dependent on the SM level: only LDL from animals on modified diet that have high SM content aggregated when treated with recombinant S-SMase. In conclusion, LDL-SM content and S-SMase activity are up-regulated in mice fed on an atherogenic diet. S-SMase mediates diet-induced changes in LDL ceramide content and aggregation. S-SMase effectiveness in inducing aggregation is dependent on diet-induced enrichment of LDL with SM, possibly through increased hepatic synthesis.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Blood Vessels / cytology
  • Blood Vessels / drug effects
  • Blood Vessels / metabolism
  • Ceramides / blood
  • Ceramides / metabolism
  • Diet, Atherogenic / adverse effects
  • Diet, High-Fat / adverse effects*
  • Fatty Acids / analysis
  • Female
  • Lipoproteins, LDL / metabolism*
  • Liver / drug effects
  • Liver / metabolism
  • Macrophages / drug effects
  • Macrophages / enzymology
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Mutant Strains
  • Receptors, Lipoprotein / genetics*
  • Receptors, Lipoprotein / metabolism
  • Sphingolipids / blood
  • Sphingolipids / metabolism*
  • Sphingomyelin Phosphodiesterase / blood
  • Sphingomyelin Phosphodiesterase / metabolism*

Substances

  • Ceramides
  • Fatty Acids
  • IDL receptor
  • Lipoproteins, LDL
  • Receptors, Lipoprotein
  • Sphingolipids
  • Sphingomyelin Phosphodiesterase